Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brain Neoplasms
|
163 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Colon Carcinoma
|
240 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1 | 2010 | 2010 | |||||
Differentiated Thyroid Gland Carcinoma
|
37 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Erectile dysfunction
|
17 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Esophageal carcinoma
|
223 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Esophageal Neoplasms
|
60 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Hematologic Neoplasms
|
37 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
leukemia
|
76 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Leukemia, Myelocytic, Acute
|
215 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Lip and Oral Cavity Carcinoma
|
95 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1 | 2014 | 2014 | |||||
Malignant neoplasm of esophagus
|
66 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Malignant neoplasm of mouth
|
100 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1 | 2014 | 2014 | |||||
Malignant neoplasm of pancreas
|
136 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Malignant tumor of colon
|
135 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1 | 2010 | 2010 | |||||
melanoma
|
389 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1 | 2012 | 2012 | |||||
MYELODYSPLASTIC SYNDROME
|
53 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Myocardial Infarction
|
454 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1 | 2016 | 2016 | |||||
Non-Small Cell Lung Carcinoma
|
362 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||
Pancreatic carcinoma
|
225 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Squamous cell carcinoma of oropharynx
|
20 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
TARSAL-CARPAL COALITION SYNDROME
|
9 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Tumor Progression
|
36 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Uterine Fibroids
|
24 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
cervical cancer
|
87 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.020 | 2 | 2013 | 2014 | |||||
Cervix carcinoma
|
100 | 0.587 | 0.571 | 19 | 43552260 | stop lost | C/G,T | snp | 8.5E-06; 7.1E-02 | 3.2E-05; 5.5E-02 | 0.020 | 2 | 2013 | 2014 |